Mylan To Buy Agila Unit Of Strides For $1.6 Billion, But Pfizer, Otsuka Lurk
This article was originally published in PharmAsia News
Executive Summary
Mylan said it would move to acquire the India-based Agila Specialties, a wholly owned subsidiary of Strides Arcolab, for $1.6 billion.